MktsMarkets

Lisata Therapeutics, Inc.
NASDAQ: LSTAKey statistics
LSTA News
Stories mentioning LSTA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 100.00 | 0.00 | 70.00 | 0.00 | 1,000 | 0.00 | 0.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 2,455 | 2,685 | 3,245 | 2,794 | 2,922 | |||
| Total Operating Expenses | 4,942 | 3,180 | 4,414 | 4,938 | 5,847 | 5,949 | 5,336 | 5,523 |
| Operating Income (Loss) | (4,942) | (3,080) | (4,414) | (4,868) | (5,847) | (4,949) | (5,336) | (5,523) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (54.00) | (15.00) | (18.00) | (7.00) | (105.00) | (11.00) | (45.00) | (14.00) |
| Pretax Income | (4,876) | (2,954) | (4,249) | (4,659) | (5,686) | (4,610) | (4,930) | (5,044) |
| Tax Provision | (387.00) | 0.00 | 0.00 | 0.00 | (962.00) | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (4,489) | (2,954) | (4,249) | (4,659) | (4,724) | (4,610) | (4,930) | (5,044) |
| Earnings Per Share (Basic) | (0.50) | (0.34) | (0.49) | (0.54) | (0.55) | (0.55) | (0.59) | (0.61) |
| Earnings Per Share (Diluted) | (0.50) | (0.34) | (0.49) | (0.54) | (0.55) | (0.55) | (0.59) | (0.61) |
| Weighted Average Shares Outstanding (Basic) | 9,006 | 8,687 | 8,738 | 8,605 | 8,602 | 8,329 | 8,321 | 8,308 |
| Weighted Average Shares Outstanding (Diluted) | 9,006 | 8,687 | 8,738 | 8,605 | 8,602 | 8,329 | 8,321 | 8,308 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About LSTA
Lisata Therapeutics, Inc. (NASDAQ: LSTA) is a stock listed on the Nasdaq Stock Market under the ticker symbol LSTA. It last traded at $0.9900 (Nov 5, 2026, 4:00 PM ET), down 6.5% on the day. That gives Lisata Therapeutics a market capitalisation of $10.9M.
Over the past 52 weeks LSTA has traded between $0.9600 and $5.07.
Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $4.5M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $0 | -$4.5M | — |
| Dec 31, 2025 | $100.0K | -$3.0M | -2954.0% |
| Sep 30, 2025 | $0 | -$4.2M | — |
| Jun 30, 2025 | $70.0K | -$4.7M | -6655.7% |
From Lisata Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…